Results

Total Results: 1,077 records

Showing results for "phase".

381. Imaging Techniques for the Surveillance, Diagnosis, and Staging of Hepatocellular Carcinoma | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/liver-cancer/research-protocol
     December 01, 2019 - The diagnosis phase involves the use of additional tests (radiological and/or histopathological) to confirm … technology is currently in use or not, and the technical aspects of each technology (such as row number, phase

382. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists five topics for which (1) preliminary phase III data for drugs were … A phase IV trial is ongoing for patients with tuberculosis. … Failure to determine these thresholds during Phase 2 is believed to be one of the main reasons for … Phase 3 failures.”9 One phase IV clinical trial (NCT01960257) is ongoing to evaluate the cost and perception

383. Environmental, Clinical and Economic Outcomes of Hospital Resources to Prevent Hospital-Acquired Infections (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prevent-hai-protocol.pdf
     April 16, 2024 - ,ab) #15 RCTs ('random sample'/de OR 'randomization'/de OR 'randomized controlled trial'/exp OR 'phase … 3':ti,ab OR 'phase iii':ti,ab OR random*:ti,ab OR RCT:ti,ab) #16 Observational/ Cohort Studies/

384. ENVIRONMENTAL PROTECTION AGENCY (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/manges.pdf
     January 06, 2017 - ENVIRONMENTAL PROTECTION AGENCY INNOVATIONS CONFERENCE -- ENVIRONMENTAL PROTECTION AGENCY SPEAKER: ELLEN MANGES, SENIOR ADVISOR, OFFICE OF SOLID WASTE AND EMERGENCY RESPONSE (OSWER) ENVIRONMENTAL PROTECTION AGENCY (EPA) MANGES: My name is Ellen Manges. I'm a senior advisor. I…

385. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data for drugs were … The Horizon Scanning System is tracking several drugs in late-phase development.

386. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists two topics for which preliminary phase III data were available for a drug … The 6-month buprenorphine implant completed phase III trials, one of which was funded by the National

387. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data were available … for drugs, phase II or III data were available for devices and procedures, or some human data were

388. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III or bioequivalence … Two late-phase multicenter trials are ongoing, and we continue to track this topic.

389. Healthcare Industry Waste and Lifecycle Assessment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/lifecycle-assessment
     September 01, 2023 - with ISO 14044. 10 The method explores the energy, water, environmental impacts associated with each phase … Cradle is defined as the raw material extraction phase of the product manufacturing. … Grave describes the end-of-life phase of a product.

390. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
     December 04, 2015 - induced psychotic disorder, or prodromal phase (ultra high-risk). … phase!or!features!of!disorder,!and! antipsychotic!treatment!history?! 2.! What!are!the!benefits,! … phase!or!features!of!disorder,!and! antipsychotic!treatment!history?! (b)!!Do!the!benefits!vary! … phase!and!features!of!disorder!(e.g.,!acute!mania!vs.!maintenance!treatment![bipolar! disorder],! … from an RCT phase to a controlled, observational phase, we will consider these two different studies

391. Management of Infantile Hemangioma | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/policymaker
     December 01, 2019 - rapid initial proliferation, plateau in infants aged about 9 to 12 months, and then enter an involution phase

392. Sleep-Apnea Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
     April 01, 2012 - AHRQ Comparative Effectiveness Review Surveillance Program CER #32: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults Original release date: August 8, 2011 Surveillance Report: July, 2012 Key Findings: - The conclusions for KQ2 (phased testing), KQ3 (preoperative screening), KQ6 (compliance…

393. Cervical Ripening in the Outpatient Setting (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
     December 18, 2019 - dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress • Cervical assessment at time of admission (e.g., latent vs. active phase

394. Cervical Ripening in the Outpatient Setting | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cervical-ripening/protocol
     May 01, 2020 - dilation for fetal distress Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress Cervical assessment at time of admission (e.g., latent vs. active phase … dilation for fetal distress Cervical assessment at time of admission (e.g., latent vs. active phase

395. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. … Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized … Multicenter phase III trial studying trospium chloride in patients with overactive bladder. … A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety … Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial.

396. Supporting Patient and Consumer Involvement in Patient-Centered Outcomes Research (Video Presentation) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stakeholders-engagement-others/research
     November 01, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

397. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
     December 01, 2011 - (i.e., dye is strongly persistent after three cardiac cycles of the washout phase and either does not … that clears normally and is either gone or only mildly/moderately persistent at the end of the washout phase … (i.e., dye is gone or is mildly/moderately persistent after three cardiac cycles of the washout phase … and noticeably diminishes in intensity during the washout phase), similar to that in an uninvolved artery … Blush that is of only mild intensity throughout the washout phase but fades minimally is also classified

398. Labor Dystocia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/labor-dystocia/research-protocol
     August 01, 2020 - inertia"[tiab] OR "Uterine Atony"[tiab] OR "inefficient uterine action"[tiab] OR "prolonged deceleration phase

399. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) preliminary phase III data for drugs and … biologics or phase II data for devices and procedures were available; (2) information was compiled … Phase III trials reported that patients with SBS treated with teduglutide can significantly reduce … day), once daily.65 Clinical trials: In results of a randomized, double-blind, placebo-controlled, phase

400. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-draft-report.pdf
     December 01, 2024 - explicitly designate LDTs as devices to ensure the safety and effectiveness of these tests and will phase … U.S. population 50 years of age or older and a hypothetical phase 5 randomized controlled screening … Some have suggested modeling as a sixth phase to allow for extrapolation from empirical studies.35 Few … studies included in our review offer evidence beyond phase 2 (discrimination in known cancer cases … cohorts studies) or phase 5.